# Hepatitis c and Vitamin D and Iron Status

> **NCT03166280** · — · UNKNOWN · sponsor: **Eman Sayed Hassan Abd Allah** · enrollment: 87 (estimated)

## Conditions studied

- Hepatitis C

## Interventions

- **DRUG:** Sofosbuvir 400 mg
- **DRUG:** Daclatasvir 60 mg/day

## Key facts

- **NCT ID:** NCT03166280
- **Lead sponsor:** Eman Sayed Hassan Abd Allah
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06
- **Primary completion:** 2017-11
- **Final completion:** 2018-05
- **Target enrollment:** 87 (ESTIMATED)
- **Last updated:** 2017-05-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166280, "Hepatitis c and Vitamin D and Iron Status". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03166280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*